COLLEGIUM PHARMACEUTICAL INC (COLL)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for COLL
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| COLL | Audit Partner | 60 | ["36 years of experience serving public and private companies in the life sciences industry","Financial expertise","Audit Partner at Ernst & Young LLP since 2002","Office Managing Partner of EY’s biotechnology office in Kendall Square","East Region Biotechnology Leader","B.S. in Business Administration from Merrimack College","Certified Public Accountant (active)"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NXST | Director | 72 | [] | [] | 2013 |
Biography sourced from the proxy statement filing.
Mr. Donovan has served as an audit Partner at Ernst & Young LLP ( EY ) since 2002. He has held several leadership roles at EY including Office Managing Partner of EY s biotechnology office in Kendall Square from 2014 to 2024 and East Region Biotechnology Leader. Mr. Donovan brings to our Board financial expertise obtained from his extensive business, accounting and financial background from over 36 years of experience serving public and private companies in the life sciences industry. During his tenure at EY, he has worked on hundreds of private and public company audits, private and public financings including IPOs, M&A transactions, corporate license and collaboration agreements, spin-outs and product launches. Mr. Donovan received a B.S. in Business Administration from Merrimack College and is a Certified Public Accountant (active). Skills & Qualifications : We believe that Mr. Donovan s perspective and experience as audit Partner and in other leadership roles at EY in the biotechnology industry provide him with the qualifications and skills to serve as a director.